Primary Site >> Colorectal Cancer
Gene >> NAMPT
| 1. | |||||||||||
| Journal: | FEBS Lett. 1999 Dec 10;463(1-2):77-82. | ||||||||||
| Title: | A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization. | ||||||||||
| Author: | Hufton, S E|Moerkerk, P T|Brandwijk, R|de Bruine, A P|Arends, J W|Hoogenboom, H R | ||||||||||
| PMID: | 10601642 | ||||||||||
| 2. | |||||||||||
| Journal: | Int J Cancer. 2002 Sep 10;101(2):118-27. | ||||||||||
| Title: | Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer. | ||||||||||
| Author: | Van Beijnum, Judy R|Moerkerk, Peter T M|Gerbers, Andrea J|De Bruine, Adriaan P|Arends, Jan-Willem|Hoogenboom, Hennie R|Hufton, Simon E | ||||||||||
| PMID: | 12209988 | ||||||||||
| 3. | |||||||||||
| Journal: | J Endocrinol Invest. 2007 Feb;30(2):138-44. | ||||||||||
| Title: | Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions. | ||||||||||
| Author: | Pilz, S|Mangge, H|Obermayer-Pietsch, B|Marz, W | ||||||||||
| PMID: | 17392604 | ||||||||||
| 4. | |||||||||||
| Journal: | Cancer Sci. 2010 May;101(5):1286-91. | ||||||||||
| Title: | Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. | ||||||||||
| Author: | Nakajima, Takako Eguchi|Yamada, Yasuhide|Hamano, Tetsutaro|Furuta, Koh|Matsuda, Takahisa|Fujita, Shin|Kato, Ken|Hamaguchi, Tetsuya|Shimada, Yasuhiro | ||||||||||
| PMID: | 20331631 | ||||||||||
| 5. | |||||||||||
| Journal: | Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):E187-96. | ||||||||||
| Title: | The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop. | ||||||||||
| Author: | Menssen, Antje|Hydbring, Per|Kapelle, Karsten|Vervoorts, Jorg|Diebold, Joachim|Luscher, Bernhard|Larsson, Lars-Gunnar|Hermeking, Heiko | ||||||||||
| PMID: | 22190494 | ||||||||||
| 6. | |||||||||||
| Journal: | J Cell Physiol. 2013 May;228(5):1017-24. | ||||||||||
| Title: | Visfatin induces stromal cell-derived factor-1 expression by beta1 integrin signaling in colorectal cancer cells. | ||||||||||
| Author: | Huang, Wen-Shih|Chen, Cheng-Nan|Sze, Chun-I|Teng, Chih-Chuan | ||||||||||
| PMID: | 23042611 | ||||||||||
| 7. | |||||||||||
| Journal: | Cytokine. 2013 Apr;62(1):81-5. | ||||||||||
| Title: | Circulating levels of novel adipocytokines in patients with colorectal cancer. | ||||||||||
| Author: | Fazeli, Mohammad Sadegh|Dashti, Habibollah|Akbarzadeh, Samad|Assadi, Majid|Aminian, Ali|Keramati, Mohammad Reza|Nabipour, Iraj | ||||||||||
| PMID: | 23474107 | ||||||||||
| 8. | |||||||||||
| Journal: | Bratisl Lek Listy. 2013;114(7):394-7. | ||||||||||
| Title: | Adipocytokine levels of colon cancer patients before and after treatment. | ||||||||||
| Author: | Kosova, F|Coskun, T|Kaya, Y|Kara, E|Ari, Z | ||||||||||
| PMID: | 23822624 | ||||||||||
| 9. | |||||||||||
| Journal: | PLoS One. 2013 Jul 29;8(7):e69963. | ||||||||||
| Title: | Nicotinamide phosphoribosyl transferase (Nampt) is a target of microRNA-26b in colorectal cancer cells. | ||||||||||
| Author: | Zhang, Chenpeng|Tong, Jinlu|Huang, Gang | ||||||||||
| PMID: | 23922874 | ||||||||||
| 10. | |||||||||||
| Journal: | Int J Mol Cell Med. 2013 Summer;2(3):143-50. | ||||||||||
| Title: | Resistin and Visfatin Expression in HCT-116 Colorectal Cancer Cell Line. | ||||||||||
| Author: | Ghaemmaghami, Sara|Mohaddes, Seyed Mojtaba|Hedayati, Mehdi|Gorgian Mohammadi, Masumeh|Dehbashi, Golnoosh | ||||||||||
| PMID: | 24551805 | ||||||||||
| 11. | |||||||||||
| Journal: | Pharmacol Rep. 2014 Oct;66(5):902-7. | ||||||||||
| Title: | Association between chemotherapy and plasma adipokines in patients with colorectal cancer. | ||||||||||
| Author: | Slomian, Grzegorz|Swietochowska, Elzbieta|Malinowska-Borowska, Jolanta|Kasperczyk, Slawomir|Rogalska, Anna|Nowak, Przemyslaw | ||||||||||
| PMID: | 25149999 | ||||||||||
| 12. | |||||||||||
| Journal: | Eur J Histochem. 2014 Sep 12;58(3):2408. | ||||||||||
| Title: | Changes in subcellular localization of visfatin in human colorectal HCT-116 carcinoma cell line after cytochalasin B treatment. | ||||||||||
| Author: | Buldak, R J|Skonieczna, M|Buldak, L|Matysiak, N|Mielanczyk, L|Wyrobiec, G|Kukla, M|Michalski, M|Zwirska-Korczala, K | ||||||||||
| PMID: | 25308845 | ||||||||||
| 13. | |||||||||||
| Journal: | PLoS One. 2014 Dec 8;9(12):e114019. | ||||||||||
| Title: | Metabolomics analysis of metabolic effects of nicotinamide phosphoribosyltransferase (NAMPT) inhibition on human cancer cells. | ||||||||||
| Author: | Tolstikov, Vladimir|Nikolayev, Alexander|Dong, Sucai|Zhao, Genshi|Kuo, Ming-Shang | ||||||||||
| PMID: | 25486521 | ||||||||||
| 14. | |||||||||||
| Journal: | J Cancer. 2015 Jul 16;6(9):849-58. | ||||||||||
| Title: | Regulative Effect of Nampt on Tumor Progression and Cell Viability in Human Colorectal Cancer. | ||||||||||
| Author: | Lv, Xiaoqun|Zhang, Lingyun|Zhu, Yanyan|Said, Harun M|Shi, Jimin|Xu, Guoxiong | ||||||||||
| PMID: | 26284136 | ||||||||||
| 15. | |||||||||||
| Journal: | J Physiol Pharmacol. 2015 Aug;66(4):557-66. | ||||||||||
| Title: | Viability and oxidative response of human colorectal HCT-116 cancer cells treated with visfatin/eNampt in vitro. | ||||||||||
| Author: | Buldak, R J|Gowarzewski, M|Buldak, L|Skonieczna, M|Kukla, M|Polaniak, R|Zwirska-Korczala, K | ||||||||||
| PMID: | 26348080 | ||||||||||
| 16. | |||||||||||
| Journal: | Biomed Res Int. 2015;2015:523930. | ||||||||||
| Title: | Nampt/PBEF/visfatin upregulation in colorectal tumors, mirrored in normal tissue and whole blood of colorectal cancer patients, is associated with metastasis, hypoxia, IL1beta, and anemia. | ||||||||||
| Author: | Neubauer, Katarzyna|Misa, Iwona Bednarz|Diakowska, Dorota|Kapturkiewicz, Bartosz|Gamian, Andrzej|Krzystek-Korpacka, Malgorzata | ||||||||||
| PMID: | 26075243 | ||||||||||
| 17. | |||||||||||
| Journal: | Asia Pac J Clin Oncol. 2016 Mar;12(1):e65-74. | ||||||||||
| Title: | Association of plasma visfatin with risk of colorectal cancer: An observational study of Chinese patients. | ||||||||||
| Author: | Chen, Mingwei|Wang, Youming|Li, Yongxiang|Zhao, Lili|Ye, Shuai|Wang, Shenyi|Yu, Changjun|Xie, Huijuan | ||||||||||
| PMID: | 23910020 | ||||||||||
| 18. | |||||||||||
| Journal: | Oncotarget. 2016 May 31;7(22):32306-17. | ||||||||||
| Title: | Visfatin is involved in promotion of colorectal carcinoma malignancy through an inducing EMT mechanism. | ||||||||||
| Author: | Yang, Jing|Zhang, Kun|Song, Haixing|Wu, Mingbo|Li, Jingyi|Yong, Ziyi|Jiang, Sheng|Kuang, Xi|Zhang, Tao | ||||||||||
| PMID: | 27058759 | ||||||||||
| 19. | |||||||||||
| Journal: | Med J Islam Repub Iran. 2016 Jan 24;30:320. eCollection 2016. | ||||||||||
| Title: | Visfatin level in patients with colorectal adenoma. | ||||||||||
| Author: | Fazeli, Mohammad Sadegh|Keramati, Mohammad Reza|Rahimi, Azam|Kazemeini, Alireza|Banoei, Mohammad Mehdi|Dashti, Habibollah|Fazeli, Amir Reza | ||||||||||
| PMID: | 27390690 | ||||||||||
| 20. | |||||||||||
| Journal: | Postepy Hig Med Dosw (Online). 2016 Aug 12;70(0):844-9. | ||||||||||
| Title: | Role of omentin and chemerin in metabolic syndrome and tumor diseases. | ||||||||||
| Author: | Szydlo, Blazej|Kiczmer, Pawel|Swietochowska, Elzbieta|Ostrowska, Zofia | ||||||||||
| PMID: | 27516571 | ||||||||||
| 21. | |||||||||||
| Journal: | Postepy Hig Med Dosw (Online). 2017 Apr 12;71(0):281-290. | ||||||||||
| Title: | Chemotherapy and plasma adipokines level in patients with colorectal cancer. | ||||||||||
| Author: | Slomian, Grzegorz|Swietochowska, Elzbieta|Nowak, Grzegorz|Pawlas, Krystyna|Zelazko, Aleksandra|Nowak, Przemyslaw | ||||||||||
| PMID: | 28402255 | ||||||||||
| 22. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2017 Aug;80(2):395-403. | ||||||||||
| Title: | Visfatin mediates doxorubicin resistance in human colorectal cancer cells via up regulation of multidrug resistance 1 (MDR1). | ||||||||||
| Author: | Yan, Xiaofei|Zhao, Jian|Zhang, Rui | ||||||||||
| PMID: | 28667355 | ||||||||||
| 23. | |||||||||||
| Journal: | Clin Cancer Res. 2018 Mar 1;24(5):1202-1215. | ||||||||||
| Title: | NAMPT Is a Potent Oncogene in Colon Cancer Progression that Modulates Cancer Stem Cell Properties and Resistance to Therapy through Sirt1 and PARP. | ||||||||||
| Author: | Lucena-Cacace, Antonio|Otero-Albiol, Daniel|Jimenez-Garcia, Manuel P|Munoz-Galvan, Sandra|Carnero, Amancio | ||||||||||
| PMID: | 29203587 | ||||||||||
| 24. | |||||||||||
| Journal: | Oncotarget. 2018 Mar 27;9(23):16451-16461. | ||||||||||
| Title: | Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment. | ||||||||||
| Author: | Ogino, Yoko|Sato, Akira|Uchiumi, Fumiaki|Tanuma, Sei-Ichi | ||||||||||
| PMID: | 29662658 | ||||||||||
| 25. | |||||||||||
| Journal: | Diabetes Metab Syndr. 2018 Sep;12(5):807-812. | ||||||||||
| Title: | The role of metabolic syndrome variant in the malignant tumors progression. | ||||||||||
| Author: | Yunusova, Natalia V|Kondakova, Irina V|Kolomiets, Larisa A|Afanas'ev, Sergey G|Kishkina, Anastasia Yu|Spirina, Liudmila V | ||||||||||
| PMID: | 29699953 | ||||||||||
| 26. | |||||||||||
| Journal: | J Surg Oncol. 2018 Jun;117(8):1833-1840. | ||||||||||
| Title: | Upregulation of the adipokine genes ADIPOR1 and SPP1 is related to poor survival outcomes in colorectal cancer. | ||||||||||
| Author: | Choe, Eun K|Yi, Jin W|Chai, Young J|Park, Kyu J | ||||||||||
| PMID: | 29761507 | ||||||||||
| 27. | |||||||||||
| Journal: | Cell Oncol (Dordr). 2018 Oct;41(5):485-494. | ||||||||||
| Title: | Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation. | ||||||||||
| Author: | Kraus, Dominik|Reckenbeil, Jan|Veit, Nadine|Kuerpig, Stefan|Meisenheimer, Michael|Beier, Imke|Stark, Helmut|Winter, Jochen|Probstmeier, Rainer | ||||||||||
| PMID: | 29949049 | ||||||||||
| 28. | |||||||||||
| Journal: | J Cell Physiol. 2018 Sep 7. | ||||||||||
| Title: | Nicotinamide phosphoribosyl transferase regulates cell growth via the Sirt1/P53 signaling pathway and is a prognosis marker in colorectal cancer. | ||||||||||
| Author: | Pan, Jing-Hua|Zhou, Hong|Zhu, Sheng-Bin|Huang, Jin-Lian|Zhao, Xiao-Xu|Ding, Hui|Qin, Li|Pan, Yun-Long | ||||||||||
| PMID: | 30191976 | ||||||||||